Top entities: Regencell Bioscience Holdings, Rosen Law Firm, Philip Kim, Lawrence Rosen.

What category does this event fall under?

Business — classified as class action.

What is the sentiment of coverage?

Aggregate sentiment score: -50 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Is this event still developing?

This is an active story, last updated May 11, 2026. Coverage continues to evolve.

Business class action

Regencell Bioscience Class Action Lawsuit

Q: When did this event occur?

First reported Apr 27, 2026; last updated May 11, 2026.

Q: What is the market impact?

Direct. The class action lawsuit against Regencell Bioscience Holdings could lead to significant financial liabilities for the company, potentially impacting its stock price negatively.

Analysis based on 21 articles · First reported Apr 27, 2026 · Last updated May 11, 2026

Sentiment

-50

Attention

Articles

Market Impact

Direct

Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

Market Impact

The class action lawsuit against Regencell Bioscience Holdings could lead to significant financial liabilities for the company, potentially impacting its stock price negatively. For investors who purchased Regencell Bioscience Holdings securities during the Class Period, there is an opportunity for compensation through the lawsuit.

Biotechnology Legal Services

Event Summary

Rosen Law Firm has announced a class action lawsuit against Regencell Bioscience Holdings Limited, alleging that the company made false and misleading statements and was vulnerable to market manipulation between October 28, 2024, and October 31, 2025. This alleged conduct exposed investors to significant financial risk and subjected Regencell Bioscience Holdings to potential regulatory scrutiny and reputational harm. The Rosen Law Firm is actively encouraging investors to join the lawsuit, with a lead plaintiff deadline set for June 23, 2026. Attorneys Philip Kim and Lawrence Rosen are key contacts for investors seeking to participate.

Key Actions

100 Rosen Law Firm announces class action lawsuit Regencell Bioscience Holdings

Entities Involved

stock

Regencell Bioscience Holdings

Regencell Bioscience Holdings is the defendant in a class action lawsuit alleging market manipulation and misleading statements, which exposed investors to significant financial risk and reputational harm.

Importance 100 Sentiment -50

priv

Rosen Law Firm

Rosen Law Firm is initiating and encouraging investors to join a class action lawsuit against Regencell Bioscience Holdings, representing purchasers of its securities.

Importance 90 Sentiment 20

per

Philip Kim

Philip Kim, an attorney at Rosen Law Firm, is a contact person for investors interested in joining the class action lawsuit against Regencell Bioscience Holdings.

Importance 40 Sentiment 10

per

Lawrence Rosen

Lawrence Rosen, founding partner of Rosen Law Firm, is mentioned as a key figure in the firm, which is leading the class action against Regencell Bioscience Holdings.

Importance 40 Sentiment 10

NEWSDESK

Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard